•
Apr 03, 2021

Thermo Fisher Q1 2021 Earnings Report

Thermo Fisher Scientific reported a significant increase in revenue and earnings per share due to the COVID-19 response and growth in the base business.

Key Takeaways

Thermo Fisher Scientific reported a strong first quarter in 2021, with revenue increasing by 59% to $9.91 billion and GAAP diluted EPS increasing by 198% to $5.88. The company's performance was driven by its role in enabling the COVID-19 response and accelerated growth in the base business. They also announced an agreement to acquire PPD, Inc. after the quarter end.

Revenue increased 59% to $9.91 billion.

GAAP diluted earnings per share (EPS) increased 198% to $5.88.

Adjusted EPS increased 145% to $7.21.

The company continued to play a significant role in enabling the COVID-19 response.

Total Revenue
$9.91B
Previous year: $6.23B
+59.0%
EPS
$7.21
Previous year: $2.94
+145.2%
Organic Revenue Growth
53%
Adjusted Operating Margin
35.4%
Previous year: 22.1%
+60.2%
Gross Profit
$5.35B
Previous year: $2.87B
+86.7%
Cash and Equivalents
$5.58B
Previous year: $2.98B
+87.3%
Free Cash Flow
$1.36B
Previous year: $107M
+1166.4%
Total Assets
$65.9B
Previous year: $58.7B
+12.3%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide updates on its 2021 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income